Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML)
about
Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML)
description
scientific article published on 20 March 2019
@en
name
Discovery and characterization ...... Chronic Myeloid Leukemia (CML)
@en
type
label
Discovery and characterization ...... Chronic Myeloid Leukemia (CML)
@en
prefLabel
Discovery and characterization ...... Chronic Myeloid Leukemia (CML)
@en
P2093
P1476
Discovery and characterization ...... Chronic Myeloid Leukemia (CML)
@en
P2093
Beilei Wang
Cheng Chen
P304
P356
10.1080/15384047.2019.1579958
P577
2019-03-20T00:00:00Z